Axonics Inc (AXNX) Stock Analyst Ratings
USA - NASDAQ:AXNX - US05465P1012 - Common Stock
70.98 USD
+0.53 (+0.75%)
70.98 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 68% to AXNX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 73.33. This target is 3.31% above the current price.
AXNX was analyzed by 19 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about AXNX.
In the previous month the buy percentage consensus was at a similar level.
AXNX was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-08 | Needham | Reiterate | Hold |
| 2024-08-05 | Needham | Reiterate | Hold |
| 2024-05-06 | Needham | Reiterate | Hold |
| 2024-02-29 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-01-17 | Needham | Downgrade | Buy -> Hold |
| 2024-01-16 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-01-12 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-01-12 | CL King | Downgrade | Buy -> Neutral |
| 2024-01-12 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-01-12 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-01-10 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-01-09 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2023-12-22 | Truist Securities | Maintains | Buy -> Buy |
| 2023-10-31 | Needham | Maintains | Buy -> Buy |
| 2023-10-31 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-16 | Leerink Partners | Initiate | Outperform |
| 2023-07-28 | Needham | Maintains | Buy -> Buy |
| 2023-07-28 | Keybanc | Maintains | Overweight -> Overweight |
| 2023-07-28 | Baird | Maintains | Outperform -> Outperform |
| 2023-07-19 | Baird | Initiate | Outperform |
| 2023-07-14 | Mizuho | Reiterate | Buy -> Buy |
| 2023-07-13 | Keybanc | Initiate | Overweight |
| 2023-07-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-05-23 | CL King | Initiate | Buy |
| 2023-05-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-05-12 | Needham | Reiterate | Buy -> Buy |
| 2023-05-02 | Needham | Maintains | Buy |
| 2023-05-02 | RBC Capital | Reiterate | Outperform |
| 2023-04-17 | Truist Securities | Maintains | Buy |
Axonics Inc / AXNX FAQ
What is the price target for AXNX stock?
19 analysts have analysed AXNX and the average price target is 73.33 USD. This implies a price increase of 3.31% is expected in the next year compared to the current price of 70.98.
What is the consensus rating for AXNX stock?
The consensus rating for Axonics Inc (AXNX) is 68.4211 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts cover Axonics Inc (AXNX) stock?
The number of analysts covering Axonics Inc (AXNX) is 19.